Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CUE
CUE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CUE News
Cue Biopharma CEO Resignation Leads to 8% Stock Drop
3d ago
stocktwits
CUE Stock Declines Following CEO's Departure After Only Six Months
3d ago
stocktwits
Cue Biopharma Appoints New Interim CEO
3d ago
seekingalpha
Cue Biopharma Appoints New CEO Amid Leadership Transition
3d ago
Newsfilter
Cue Biopharma Reports Strong Q4 Earnings with Significant Revenue Growth
Mar 17 2026
seekingalpha
Cue Biopharma Reports Strong Q4 and Full-Year 2025 Financial Results
Mar 17 2026
NASDAQ.COM
Biotech Stocks Surge: Coherus Up 9.09% in After-Hours Trading
Jan 23 2026
NASDAQ.COM
IO Biotech (IOBT) Explores Strategic Alternatives, Stock Surges 19.36%
Jan 22 2026
NASDAQ.COM
Cue Biopharma Prices $10 Million Public Offering of Common Stock
Dec 19 2025
Globenewswire
Cue Biopharma Launches $10M Underwritten Public Offering; Stock Declines
Dec 19 2025
SeekingAlpha
Cue Biopharma Launches Underwritten Public Offering with 15% Additional Shares Option
Dec 18 2025
Globenewswire
Cue Biopharma Launches Underwritten Public Offering with 15% Additional Shares Option
Dec 18 2025
Newsfilter
Biotech Stocks Rise in After-Hours Trading Driven by Data Expectations and Momentum Buying
Dec 11 2025
NASDAQ.COM
Cue Biopharma (CUE) Price Target Raised by 25% to $5.10
Dec 06 2025
NASDAQ.COM
Healthcare and Biotech Stocks Surge in After-Hours Trading: Sensei, Praxis, Cooper, Vanda, Cue, ResMed
Dec 05 2025
NASDAQ.COM
ImmunoScape, Based in Singapore, Leads Development of Advanced Cell Therapy for Solid Tumors; Reveals Major Licensing Agreement and New Board and SAB Appointments
Nov 13 2025
Newsfilter
Show More News
